Cargando…
Multi-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan
BACKGROUND: Controversy exists about the optimal management of a patent ductus arteriosus (PDA) in preterm infants. A persistent PDA is associated with neonatal mortality and morbidity, but causality remains unproven. Although both pharmacological and/or surgical treatment are effective in PDA closu...
Autores principales: | Hundscheid, Tim, Donders, Rogier, Onland, Wes, Kooi, Elisabeth M. W., Vijlbrief, Daniel C., de Vries, Willem B., Nuytemans, Debbie H. G. M., van Overmeire, Bart, Mulder, Antonius L., de Boode, Willem P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444433/ https://www.ncbi.nlm.nih.gov/pubmed/34526095 http://dx.doi.org/10.1186/s13063-021-05594-x |
Ejemplares similares
-
Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial)
por: Hundscheid, Tim, et al.
Publicado: (2018) -
Factors Associated With Benefit of Treatment of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis
por: Jansen, Esther J. S., et al.
Publicado: (2021) -
Conservative Management of Patent Ductus Arteriosus in Preterm Infants—A Systematic Review and Meta-Analyses Assessing Differences in Outcome Measures Between Randomized Controlled Trials and Cohort Studies
por: Hundscheid, Tim, et al.
Publicado: (2021) -
Survey highlighting the lack of consensus on diagnosis and treatment of patent ductus arteriosus in prematurity
por: Hundscheid, Tim, et al.
Publicado: (2022) -
Application of NPE in the assessment of a patent ductus arteriosus
por: van Laere, David, et al.
Publicado: (2018)